Center-Authored Papers

Filters: Author is McIntosh, Martin W  [Clear All Filters]
Journal Article
Bandeira N, Nesvizhskii A, McIntosh MW.  2011.  Advancing next-generation proteomics through computational research.. Journal of proteome research. 10(7):2895.
Anderson GL, McIntosh MW, Wu LL, Barnett M, Goodman GE, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N et al..  2010.  Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.. Journal of the National Cancer Institute. 102(1):26-38. Abstract
McIntosh MW, Fitzgibbon M.  2009.  Biomarker validation by targeted mass spectrometry.. Nature biotechnology. 27(7):622-3.
Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G et al..  2009.  Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.. Molecular & cellular proteomics : MCP. 8(3):451-66. Abstract
Etzioni R, Urban ND, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L.  2003.  The case for early detection.. Nature reviews. Cancer. 3(4):243-52. Abstract
Schummer M, Green A, Beatty JD, Karlan BY, Karlan S, Gross J, Thornton S, McIntosh MW, Urban ND.  2010.  Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection.. PloS one. 5(2):e9122. Abstract
Amon LM, Pitteri SJ, Li CI, McIntosh MW, Ladd J, Disis ML, Porter PL, Wong C-H, Zhang Q, Prentice RL et al..  2012.  Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.. Cancer research. Abstract
Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H et al..  2010.  Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.. Cancer research. 70(21):8598-606. Abstract
Li CI, Mirus JE, Zhang Y, Ramirez AB, Ladd JJ, Prentice RL, McIntosh MW, Hanash SM, Lampe PD.  2012.  Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.. Breast cancer research and treatment. 135(2):611-8. Abstract
Hondowicz BD, Schwedhelm KV, Kas A, Tasch MA, Rawlings C, Ramchurren N, McIntosh M, D'Amico LA, Sanda S, Standifer NE et al..  2012.  Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries.. PloS one. 7(1):e29949. Abstract
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
Chen R, Pan S, Duan X, Nelson BH, Sahota RA, de Rham S, Kozarek RA, McIntosh MW, Brentnall TA.  2010.  Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia.. Molecular cancer. 9:149. Abstract
Laszlo GS, Harrington KH, Gudgeon CJ, Beddoe ME, Fitzgibbon MP, Ries RE, Lamba JK, McIntosh MW, Meshinchi S, Walter RB.  2016.  Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia.. Oncotarget. 7(28):43281-43294. Abstract
Bates JG, Salzman J, May D, Garcia PB, Hogan GJ, McIntosh M, Schlissel MS, Brown PO.  2012.  Extensive gene-specific translational reprogramming in a model of B cell differentiation and abl-dependent transformation.. PloS one. 7(5):e37108. Abstract
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban ND, Mor G, Bast RC, Moore LE et al..  2011.  A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
Zhao W, Fitzgibbon M, Bergan L, Clegg N, Crispin D, Mills GB, McIntosh M.  2017.  Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets.. Cancer journal (Sudbury, Mass.). 23(2):108-114. Abstract
Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash SM, Agus DB, McIntosh MW, Mallick P.  2011.  Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.. PloS one. 6(7):e23090. Abstract
Drescher CW, Hawley SH, Thorpe JD, Marticke S, McIntosh MW, Gambhir SS, Urban ND.  2012.  Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.. Cancer prevention research (Philadelphia, Pa.). Abstract
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
Eckels J, Hussey P, Nelson EK, Myers T, Rauch A, Bellew M, Connolly B, Law W, Eng JK, Katz J et al..  2011.  Installation and use of LabKey Server for proteomics.. Current protocols in bioinformatics / editoral board, Andreas D. Baxevanis ... [et al.]. Chapter 13:Unit13.5.. Abstract
Whitmore TE, Peterson A, Holzman T, Eastham A, Amon L, McIntosh M, Ozinsky A, Nelson PS, Martin DB.  2012.  Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.. Journal of proteome research. 11(5):2653-65. Abstract
Amon LM, Law W, Fitzgibbon MP, Gross JA, O'Briant K, Peterson A, Drescher CW, Martin DB, McIntosh MW.  2010.  Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer.. PloS one. 5(6):e11137. Abstract
Urban ND, Thorpe J, Karlan BY, McIntosh MW, Palomares MR, Daly MB, Paley P, Drescher CW.  2012.  Interpretation of Single and Serial Measures of HE4 and CA125 in Asymptomatic Women at High Risk for Ovarian Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(11):2087-94. Abstract
May D, Pan S, Crispin DA, Lai K, Bronner MP, Hogan J, Hockenbery DM, McIntosh MW, Brentnall TA, Chen R.  2011.  Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.. Journal of proteome research. 10(1):200-9. Abstract
Pan S, Tamura Y, Chen R, May D, McIntosh MW, Brentnall TA.  2012.  Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy.. Molecular bioSystems. 8(11):2850-6. Abstract